13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Molecular Neuroscience
Molecular neuroscience focuses on understanding the molecular basis of brain function and neurological diseases. This field investigates how molecules such as proteins, RNA, and lipids influence neural processes like synaptic transmission, neural growth, and plasticity. The study of ion channels, receptors, and intracellular signaling pathways is crucial for understanding both normal brain function and disease states. Recent advances in molecular technologies have allowed for the identification of new biomarkers and therapeutic targets for diseases like multiple sclerosis and amyotrophic lateral sclerosis (ALS). Additionally, research in molecular neuroscience is exploring how genetic mutations and environmental factors interact at the molecular level, offering promising avenues for personalized medicine in neurological care.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Ananya Rajasekaran, ThinkNeuro, United States